Skip to content

Insights

04 July 2018

Focus Antitrust - 4 July 2018

In The News

CMA applies for permission to appeal Pfizer/Flynn Pharma excessive pricing judgment

The CMA has sought permission to appeal the judgment in the Pfizer/Flynn Pharma excessive pricing case, which overturned its abuse finding.  The judgment was handed down by the Competition Appeal Tribunal on 7 June 2018 and, if permission is granted, the appeal would be heard by the Court of Appeal.  Click here.

European Commission gives conditional approval to Tronox's acquisition of Cristal

The European Commission has approved the acquisition of Cristal by Tronox following a phase 2 investigation.  Both companies are suppliers of titanium dioxide pigment.  The approval is conditional on commitments offered by Tronox to sell its global business in titanium dioxide pigment for paper laminate.  Click here.

EU

Articles 101 and 102
  • The General Court has upheld the original fines imposed by the European Commission on subsidiaries of Sanitec for participation in the bathroom fittings cartel.  The case was remitted to the General Court by the ECJ, after the ECJ held that the General Court had erred in annulling the fines in its original decision.  Click here.
Mergers
  • The European Commission has approved the proposed creation of a joint venture between the swimming pool equipment businesses of Zodiac and Fluidra. The approval is conditional on the divestment of most of Fluidra's robotic pool cleaner business.  Click here.

UK

CMA

The CMA has referred Rentokil Initial’s purchase of Cannon Hygiene for an in-depth phase 2 merger investigation after finding competition concerns in relation to the supply of washroom products and services.  Click here.


For more information please contact Paul Stone on +44 (0)20 7203 5110 or at paul.stone@crsblaw.com.

TOP